array:5 [
  "content-type" => array:1 [
    0 => "text/html; charset=UTF-8"
  ]
  "cache-control" => array:1 [
    0 => "no-cache, private"
  ]
  "date" => array:1 [
    0 => "Sat, 23 Nov 2024 16:11:39 GMT"
  ]
  "set-cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6IkhJbERmVjc0YThQS1JMRVdhVnhqcXc9PSIsInZhbHVlIjoiZHUxaGs0VGc1cVBxb3dYZmtxaTFCQ05tTFJjcjRCeFovc3lqMTJmdWNhT3BMTzdHS1hrM2FRLzJYWEJjTy9KaDhpQ3Q1aTBTQ1NXZFhMSDhVbU1CSXJheHRiOFhvZmh2OGZ0M0VZOXNrcjF1Rld6eTBYeGhUTFBvcE5zWTBlZUciLCJtYWMiOiIxYTc3OTBjMDkxOTIzNmQ4N2E3NmIxMjE2ZDgwMWZlMTBlZTA2YTAxZDEzMjkyZjAxNzhmNTY2ODRjNzhmODYxIiwidGFnIjoiIn0%3D; expires=Tue, 26 Nov 2024 04:11:39 GMT; Max-Age=216000; path=/; secure; samesite=lax"
    1 => "alphaeurekaselectnet_session=eyJpdiI6IkdVTW1IQ0xuVm5ZaUhhdllBQVM3Nnc9PSIsInZhbHVlIjoiQ2tkc2VOR0NqSUd6VEc4ckFjbXNpMHlTa0tidnFsY3dIcGh3QTZUcGo0YlhuY1RYU0t1OGtnR2dpbFlKWUl1N3FHaStBTi9ySUgyS0lvYkNaZ09zWVN4ZGorT1BmS1QvdTU2TkFaSzE0T0dLN1hTNWZDcDJwQ0dVOElWY2ZyNHQiLCJtYWMiOiJiM2M4NjlmMDhkYmFlNWJhYmU0NzVlYmEzNTZjOTNhMTc1MmEwMDk5MTczYzAyODhiNGY1M2Y5OTI4MTk5MDUxIiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=lax"
  ]
  "Set-Cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6IkhJbERmVjc0YThQS1JMRVdhVnhqcXc9PSIsInZhbHVlIjoiZHUxaGs0VGc1cVBxb3dYZmtxaTFCQ05tTFJjcjRCeFovc3lqMTJmdWNhT3BMTzdHS1hrM2FRLzJYWEJjTy9KaDhpQ3Q1aTBTQ1NXZFhMSDhVbU1CSXJheHRiOFhvZmh2OGZ0M0VZOXNrcjF1Rld6eTBYeGhUTFBvcE5zWTBlZUciLCJtYWMiOiIxYTc3OTBjMDkxOTIzNmQ4N2E3NmIxMjE2ZDgwMWZlMTBlZTA2YTAxZDEzMjkyZjAxNzhmNTY2ODRjNzhmODYxIiwidGFnIjoiIn0%3D; expires=Tue, 26-Nov-2024 04:11:39 GMT; path=/; secure"
    1 => "alphaeurekaselectnet_session=eyJpdiI6IkdVTW1IQ0xuVm5ZaUhhdllBQVM3Nnc9PSIsInZhbHVlIjoiQ2tkc2VOR0NqSUd6VEc4ckFjbXNpMHlTa0tidnFsY3dIcGh3QTZUcGo0YlhuY1RYU0t1OGtnR2dpbFlKWUl1N3FHaStBTi9ySUgyS0lvYkNaZ09zWVN4ZGorT1BmS1QvdTU2TkFaSzE0T0dLN1hTNWZDcDJwQ0dVOElWY2ZyNHQiLCJtYWMiOiJiM2M4NjlmMDhkYmFlNWJhYmU0NzVlYmEzNTZjOTNhMTc1MmEwMDk5MTczYzAyODhiNGY1M2Y5OTI4MTk5MDUxIiwidGFnIjoiIn0%3D; path=/; secure; httponly"
  ]
]
Articles by Disease (Transitional Cell Cancer)

Anticancer Antifolates: Current Status and Future Directions

Recurrence in Bladder Cancer: A Molecular Dead End?
